Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study.
Frederiksen JL, Massacesi L, Nielsen HH, Rini A, Baldi E, Mirabella M, Antonella FFM, Lus G, Paolicelli D, Kant M, Salemi G, Aguglia U, Comi C, De Riz M, Barcella V, Flemmen HØ, Protti A, Farbu E, van Exel J, Torkildsen Ø.
Frederiksen JL, et al.
Mult Scler Relat Disord. 2024 Dec 3;93:106214. doi: 10.1016/j.msard.2024.106214. Online ahead of print.
Mult Scler Relat Disord. 2024.
PMID: 39642455
Free article.